Free Trial

Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Passes Above 50-Day Moving Average - Should You Sell?

Ono Pharmaceutical logo with Medical background

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $10.86 and traded as high as $12.75. Ono Pharmaceutical shares last traded at $12.75, with a volume of 464 shares.

Ono Pharmaceutical Stock Performance

The company has a 50 day simple moving average of $11.03 and a two-hundred day simple moving average of $10.85. The company has a market cap of $5.99 billion, a PE ratio of 12.26 and a beta of 0.57. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.80 and a current ratio of 3.55.

Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a net margin of 15.15% and a return on equity of 9.10%.

About Ono Pharmaceutical

(Get Free Report)

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.

Featured Articles

Should You Invest $1,000 in Ono Pharmaceutical Right Now?

Before you consider Ono Pharmaceutical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.

While Ono Pharmaceutical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines